arrow_back Back Filing freshness 20-F FY 2025 SEC EDGAR

Enlivex Ltd.

ENLV
$2.06 ▲ +0.09 (+4.57%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
15 Visible periods
20 Metrics
Peer-ranked Benchmarks
Price Chart
58
Health
Fair
Bullish
auto_awesome

Analytical Summary

Enlivex Ltd. shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $94.1M
Dividend Yield
Revenue Growth
Op. Margin
ROIC -0.6%
FCF / Share $-0.23
Trailing P/E 0.1x
Price / Book 0.3x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

15-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Net Income Profit after all expenses
$1.24B
↑ +8329.2%
FCF / Share Free cash flow per share
$-0.23
↑ +64.1%
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Returns
98
Financial Health
28
Cash Quality
22

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 15 years · 15 quarters